Unfors RaySafe, acquired by Fluke Biomedical in February 2014, has signed an exclusive agreement with Philips to license out the Patient Dose Management System RaySafe S1. According to a news report, the RaySafe S1 is a cloud-based patient dose tracking system launched in 2013 that helps healthcare institutions lower patient dose, improve process quality, and increase productivity in imaging workflow while reducing costs.
RaySafe had reportedly searched for a partner to help accelerate its market reach and better support healthcare institutions to avoid unnecessary radiation. Philips is launching initiatives to provide solutions that lower dose and create a safer environment for patients as well as medical staff.
According to Fluke Biomedical, each year approximately 3.6 billion x-ray examinations are performed worldwide, leading to earlier and more accurate diagnosis of medical diseases. However, considerable concern has been voiced regarding the stochastic and even deterministic impact on both patients and medical staff. There has been increased concern to launch efforts that ensure proper performance of x-ray equipment and to keep the dose to medical staff and patients as low as reasonably achievable.
“We are committed to providing innovative products and offerings to help avoid unnecessary risks,” said Magnus Kristoferson, CEO of Unfors RaySafe. “Moreover, we believe that only a holistic approach to radiation safety can effectively reduce unnecessary radiation exposure to patients and medical staff. As a consequence of this agreement, Unfors RaySafe will discontinue to market and sell the RaySafe S1 solution.”
Kristoferson says that Unfors RaySafe will continue to develop safer ease-of-use healthcare systems, focusing on quality assurance solutions, and real-time dosimetry.
Fluke Biomedical and Unfors RaySafe will share Booth #1718 at the Radiological Society of North America Annual Meeting (RSNA), running November 30th through December 5th in Chicago, Ill.